Real world evidence of calcifediol or vitamin D prescription and mortality rate of COVID-19 in a retrospective cohort of hospitalized Andalusian patients.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
03 12 2021
Historique:
received: 03 09 2021
accepted: 19 11 2021
entrez: 4 12 2021
pubmed: 5 12 2021
medline: 15 12 2021
Statut: epublish

Résumé

COVID-19 is a major worldwide health problem because of acute respiratory distress syndrome, and mortality. Several lines of evidence have suggested a relationship between the vitamin D endocrine system and severity of COVID-19. We present a survival study on a retrospective cohort of 15,968 patients, comprising all COVID-19 patients hospitalized in Andalusia between January and November 2020. Based on a central registry of electronic health records (the Andalusian Population Health Database, BPS), prescription of vitamin D or its metabolites within 15-30 days before hospitalization were recorded. The effect of prescription of vitamin D (metabolites) for other indication previous to the hospitalization was studied with respect to patient survival. Kaplan-Meier survival curves and hazard ratios support an association between prescription of these metabolites and patient survival. Such association was stronger for calcifediol (Hazard Ratio, HR = 0.67, with 95% confidence interval, CI, of [0.50-0.91]) than for cholecalciferol (HR = 0.75, with 95% CI of [0.61-0.91]), when prescribed 15 days prior hospitalization. Although the relation is maintained, there is a general decrease of this effect when a longer period of 30 days prior hospitalization is considered (calcifediol HR = 0.73, with 95% CI [0.57-0.95] and cholecalciferol HR = 0.88, with 95% CI [0.75, 1.03]), suggesting that association was stronger when the prescription was closer to the hospitalization.

Identifiants

pubmed: 34862422
doi: 10.1038/s41598-021-02701-5
pii: 10.1038/s41598-021-02701-5
pmc: PMC8642445
doi:

Substances chimiques

Vitamin D 1406-16-2
Calcifediol P6YZ13C99Q

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

23380

Subventions

Organisme : Consejería de Transformación Económica, Industria, Conocimiento y Universidades, Junta de Andalucía
ID : PAIDI2020-DOC_00350
Organisme : Centro de Investigación Biomédica en Red sobre Enfermedades Raras
ID : ACCI2018/29
Organisme : Ministerio de Ciencia e Innovación
ID : PID2020-117979RB-I00
Organisme : Instituto de Salud Carlos III
ID : IMP/0019
Organisme : Instituto de Salud Carlos III
ID : PI19/00033
Organisme : Fundación BBVA
ID : G999088Q
Organisme : H2020 Marie Skłodowska-Curie Actions
ID : 813533
Organisme : Consejería de Salud y Familias, Junta de Andalucía
ID : COVID-011-2020
Organisme : Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable
ID : CB16/10/00245

Informations de copyright

© 2021. The Author(s).

Références

Biom J. 2018 Nov;60(6):1151-1163
pubmed: 30257058
Mol Med Rep. 2016 Feb;13(2):1186-94
pubmed: 26675943
Eur J Endocrinol. 2020 Nov;183(5):R133-R147
pubmed: 32755992
J Steroid Biochem Mol Biol. 2020 Sep;202:105719
pubmed: 32535032
Am J Clin Nutr. 2021 Sep 1;114(3):1189-1199
pubmed: 34008842
Int J Infect Dis. 2021 Mar;104:58-64
pubmed: 33401034
JAMA. 2018 Sep 4;320(9):867-868
pubmed: 30105359
J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5281-e5282
pubmed: 34331760
Lancet Infect Dis. 2021 Jun;21(6):783-792
pubmed: 33636145
JACC Cardiovasc Interv. 2008 Jun;1(3):211-7
pubmed: 19463302
Clin Pharmacol Ther. 2020 Feb;107(2):369-377
pubmed: 31350853
Metabolism. 2021 Jun;119:154753
pubmed: 33774074
Aging Clin Exp Res. 2020 Jul;32(7):1195-1198
pubmed: 32377965
Eur J Clin Nutr. 2011 Mar;65(3):321-8
pubmed: 21179052
Osteoporos Int. 2018 Aug;29(8):1697-1711
pubmed: 29713796
PLoS One. 2020 Sep 17;15(9):e0239252
pubmed: 32941512
Nutrients. 2020 Jun 01;12(6):
pubmed: 32492787
Postgrad Med J. 2021 Jul;97(1149):442-447
pubmed: 32855214
Aliment Pharmacol Ther. 2020 Jun;51(12):1434-1437
pubmed: 32311755
Cochrane Database Syst Rev. 2021 May 24;5:CD015043
pubmed: 34029377
Sci Data. 2020 May 5;7(1):136
pubmed: 32371892
Endocr Rev. 2019 Aug 1;40(4):1109-1151
pubmed: 30321335
FASEB J. 2016 Mar;30(3):1367-76
pubmed: 26700731
Crit Rev Food Sci Nutr. 2021 Aug 12;:1-6
pubmed: 34384300
JAMA Netw Open. 2020 Sep 1;3(9):e2019722
pubmed: 32880651
JAMA. 2020 Oct 6;324(13):1330-1341
pubmed: 32876694
Nutrients. 2020 Sep 10;12(9):
pubmed: 32927735
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1343-e1353
pubmed: 33159440
Clin Res Cardiol. 2017 Jan;106(1):1-9
pubmed: 27557678
Endocr Connect. 2019 Nov 1;8(11):1447-1454
pubmed: 31614338
Biomedicines. 2021 May 05;9(5):
pubmed: 34063015
Gac Sanit. 2020 Mar - Apr;34(2):105-113
pubmed: 31133300
Med Drug Discov. 2020 Jun;6:100041
pubmed: 32352080
Nutrients. 2021 May 21;13(6):
pubmed: 34064175
J Bone Miner Res. 2021 Oct;36(10):1967-1978
pubmed: 34101900
FEBS J. 2020 Sep;287(17):3693-3702
pubmed: 32700398
Biochem Pharmacol. 2020 Jul;177:113955
pubmed: 32251673
Ir Med J. 2020 May 07;113(5):84
pubmed: 32603575
JAMA. 2021 Mar 16;325(11):1053-1060
pubmed: 33595634
Steroids. 2011 Nov;76(12):1305-9
pubmed: 21745487
N Engl J Med. 2016 Aug 11;375(6):501-4
pubmed: 27509097
J Endocrinol Invest. 2021 Jul 17;:
pubmed: 34273098
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Signal Transduct Target Ther. 2020 Dec 11;5(1):290
pubmed: 33311438
Clin Endocrinol (Oxf). 2021 Jun 23;:
pubmed: 34160843
Mol Med Rep. 2017 Nov;16(5):7432-7438
pubmed: 28944831
J Clin Endocrinol Metab. 2021 Oct 21;106(11):e4708-e4715
pubmed: 34139758
BioData Min. 2021 Jan 21;14(1):5
pubmed: 33478554
Stat Med. 2016 Dec 30;35(30):5642-5655
pubmed: 27549016
BMC Med Res Methodol. 2020 Aug 27;20(1):218
pubmed: 32854619
BMJ. 2017 Feb 15;356:i6583
pubmed: 28202713
Eur J Trauma Emerg Surg. 2018 Jun;44(3):385-395
pubmed: 28342097
BMC Med. 2020 Jan 15;18(1):13
pubmed: 31937304
J Steroid Biochem Mol Biol. 2020 Oct;203:105751
pubmed: 32871238
Mol Endocrinol. 2013 Dec;27(12):2116-25
pubmed: 24196349
Sci Rep. 2021 Jan 8;11(1):184
pubmed: 33420236
N Engl J Med. 2016 Dec 8;375(23):2293-2297
pubmed: 27959688

Auteurs

Carlos Loucera (C)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.
Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Seville, Spain.

María Peña-Chilet (M)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.
Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Seville, Spain.
Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain.

Marina Esteban-Medina (M)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain.
Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Seville, Spain.

Dolores Muñoyerro-Muñiz (D)

Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de Salud, Seville, Spain.

Román Villegas (R)

Subdirección Técnica Asesora de Gestión de la Información, Servicio Andaluz de Salud, Seville, Spain.

Jose Lopez-Miranda (J)

Internal Medicine Department, IMIBIC/Reina Sofia University Hospital/University of Cordoba, 14004, Córdoba, Spain.
CIBER Fisiopatologia Obesidad y Nutricion (CIBEROBN), Instituto de Salud Carlos III, 28029, Madrid, Spain.

Jesus Rodriguez-Baño (J)

Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Seville, Spain.
Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospital Universitario Virgen Macarena, Seville, Spain.
Departamento de Medicina, Universidad de Sevilla, Seville, Spain.

Isaac Túnez (I)

Departamento de Bioquimica y Biología Molecular, Facultad de Medicina y Enfermería, Universidad de Córdoba, Córdoba, Spain.
Instituto Maimónides de Investigacion Biomédica de Córdoba (IMIBIC), 14004, Córdoba, Spain.
G. Técnico de Expertos de Andalucía para Estudios de Suplementos e Intervención Nutricional Frente a Covid-19, SGIDIS, Consejería de Salud y Familias, Junta de Andalucia, Seville, Spain.
Secretaria General de Investigación, Desarrollo e Innovación en Salud, Consejería de Salud y Familias de la Junta de Andalucía, Seville, Spain.

Roger Bouillon (R)

Clinical and Experimental Endocrinology, Department of Chronic Diseases and Metabolism, KULeuven, Herestraat, 3000, Leuven, Belgium.

Joaquin Dopazo (J)

Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain. joaquin.dopazo@juntadeandalucia.es.
Institute of Biomedicine of Seville (IBIS), Hospital Virgen del Rocio, 41013, Seville, Spain. joaquin.dopazo@juntadeandalucia.es.
Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), FPS, Hospital Virgen del Rocio, 41013, Seville, Spain. joaquin.dopazo@juntadeandalucia.es.
FPS/ELIXIR-ES, Fundación Progreso y Salud (FPS), CDCA, Hospital Virgen del Rocio, 41013, Seville, Spain. joaquin.dopazo@juntadeandalucia.es.

Jose Manuel Quesada Gomez (JM)

Instituto Maimónides de Investigacion Biomédica de Córdoba (IMIBIC), 14004, Córdoba, Spain. jmquesada@uco.es.
CIBER de Fragilidad y Envejecimiento Saludable (CIBERFES), Hospital Universitario Reina Sofía, Universidad de Córdoba, Menéndez Pidal s/n, 14004, Córdoba, Spain. jmquesada@uco.es.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH